Advances in Bile Acid Metabolites and Their Receptor-Targeted Interventions in Chronic Kidney Disease
Medicine Insights · 18.11.2026 · 3 (6) · 34-48
DOI: 10.70088/8ksgw627 ↗Kurz gefasst
Fachartikel in der Zeitschrift Medicine Insights, online erschienen am 18.11.2026. Verfasst von Yi You und 2 weiteren Autor:innen. Der Volltext ist frei zugänglich (Open Access, CC BY 4.0).
Abstract (Originalsprache)
Chronic kidney disease (CKD) has traditionally been understood from a glomerular perspective: proteinuria and a decline in estimated glomerular filtration rate (eGFR) are regarded as core hallmarks of the disease, and current intervention options for CKD are limited.Recent studies have highlighted the critical role of the gut-kidney axis in the pathogenesis and management of CKD; metabolomics has shown that the accumulation of conjugated bile acids is associated with declining renal function and cardiovascular risk, whereas elevated levels of primary bile acids are associated with a lower risk of the disease.Research data, primarily from animal and cell culture models, indicate that bile acids (BAs) can influence CKD through the nuclear farnesoid X receptor (FXR) and the membrane G protein-coupled bile acid receptor (TGR5),This article provides a systematic review centered on the gut-kidney-vascular axis mediated by bile acid metabolites, elucidating the mechanisms of bile acid homeostasis remodeling and tissue damage in CKD, and highlighting that disease modification requires simultaneous targeting of specific bile acid subtypes and their receptors, rather than relying solely on existing therapies.
Zitieren
APA
You, Y., Xing, J., & Wang, M. (2026). Advances in Bile Acid Metabolites and Their Receptor-Targeted Interventions in Chronic Kidney Disease. Medicine Insights, 3(6), 34-48. https://doi.org/10.70088/8ksgw627
Vancouver
You Y, Xing J, Wang M. Advances in Bile Acid Metabolites and Their Receptor-Targeted Interventions in Chronic Kidney Disease. Medicine Insights. 2026;3(6):34-48. doi:10.70088/8ksgw627
BibTeX
@article{You2026,
author = {You, Yi and Xing, Jiangwa and Wang, Mingxiao},
title = {Advances in Bile Acid Metabolites and Their Receptor-Targeted Interventions in Chronic Kidney Disease},
journal = {Medicine Insights},
year = {2026},
volume = {3},
number = {6},
pages = {34--48},
doi = {10.70088/8ksgw627}
}
EUVIMED